The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Update on overall survival (OS) of RESCUE: An open-label, phase 2 trial of camrelizumab (C) in combination with apatinib (A) in patients with advanced hepatocellular carcinoma (HCC).
 
Yun Zhang
No Relationships to Disclose
 
Jianming Xu
No Relationships to Disclose
 
Jie Shen
No Relationships to Disclose
 
Shanzhi Gu
No Relationships to Disclose
 
Lihua Wu
No Relationships to Disclose
 
Jian Wu
No Relationships to Disclose
 
Guoliang Shao
No Relationships to Disclose
 
Yanqiao Zhang
No Relationships to Disclose
 
Li Xu
No Relationships to Disclose
 
Tao Yin
No Relationships to Disclose
 
Jingfeng Liu
No Relationships to Disclose
 
Zhenggang Ren
No Relationships to Disclose
 
Jianping Xiong
No Relationships to Disclose
 
Xianhai Mao
No Relationships to Disclose
 
Ling Zhang
No Relationships to Disclose
 
Jiayin Yang
No Relationships to Disclose
 
Lequn Li
No Relationships to Disclose
 
Xiaoming Chen
No Relationships to Disclose
 
Zhiming Wang
No Relationships to Disclose
 
Quanren Wang
Employment - Jiangsu Hengrui Medicine